Specifications. The right limits, methods, market, material, and effective date—together.

A specification is not a PDF table of tests and limits. It is an effective quality contract: which material or product, at which stage, made at which site, for which market, tested by which method, against which criteria, under which sampling plan, and with which approved justification.

Seal represents that contract as governed data connected to development, methods, materials, batches, samples, stability, regulatory commitments, changes, results, investigations, and disposition. The test plan used today can always be traced to the exact approved basis.

ICH Q6A defines specifications as tests, analytical procedures, and acceptance criteria and emphasizes that they are one part of an overall control strategy. Seal operationalizes that definition without reducing quality assurance to a limit table.

The controlled object contains tests, method references, acceptance criteria, units, calculations, reportable basis, sampling, applicability, effective dates, owners, approvals, and justification. Approved documents and customer-facing formats are generated views of that state.

This prevents a limit from being updated in a document while remaining stale in LIMS, a worksheet, a CoA template, or a contract-laboratory instruction.

Specification effective-state resolver

The correct test contract is resolved from applicability and date; users do not choose from a folder of versions.

Inputs

Material, stage, site, source, market, lifecycle and action date.

Candidates

Approved versions retain effective and superseded applicability.

Conflict

Overlaps and gaps block assignment instead of relying on analyst judgment.

Contract

Tests, methods, criteria, units and sampling resolve as one executable set.

Product, strength, dosage form, component, material grade, supplier or manufacturer where justified, process stage, site, market, registration, clinical phase, protocol, and date can influence the applicable specification.

The resolver shows both the selected specification and why competing versions do not apply. An operator or analyst never chooses from a folder of similarly named documents.

A test requirement identifies attribute, stage, method, reportable result, units, precision, calculation, sampling, criterion, conditional logic, reduced-testing rule, and required review. Criteria can be numeric ranges, enumerated outcomes, presence or absence, profile comparisons, or scientifically defined decision rules.

The same analytical method can support several tests without forcing their product-specific criteria into the method procedure.

Each test points to an effective analytical procedure and, where relevant, validated range, transfer status, site capability, instrument family, calculation, reference standard, and system-suitability requirements.

A method change identifies every specification, stability protocol, laboratory, result interpretation, filing, and open sample that may require assessment.

Lot population, containers, locations, increments, composite rules, sample quantities, reserve requirements, destructive tests, reduced or skip-lot logic, and representative-sample rationale attach to the specification and material state.

The executed sample population remains visible beside results. Passing data cannot imply batch conformance when the required sampling plan was not completed.

Release, shelf-life, in-process, characterization, registration, internal alert, and stability-trend criteria remain distinct. Timepoint, storage condition, orientation, package, pull window, and protocol define stability applicability.

The system does not apply a shelf-life limit to an initial release result simply because the attribute name matches.

Registered specifications, pharmacopoeial requirements, customer agreements, internal controls, and compendial changes connect to markets and dossiers. Where the tightest internal criterion governs execution, the registered commitments remain individually visible.

Market additions and withdrawals update applicability without rewriting historical batch evidence.

Monograph, general chapter, customer document, quality agreement, and internal technical standard references retain edition, effective date, interpretation, assessment, implementation decision, and supersession.

A copied limit is not the trace. The system preserves why it applies, how it was interpreted, and what work implemented it.

Quality target, process knowledge, clinical relevance, batch history, stability, method capability, toxicology, impurity qualification, risk assessment, and regulatory negotiation can justify the chosen tests and criteria.

The approved specification links to that rationale rather than merely stating the final number. Later reviewers can distinguish a registered boundary from an internal control chosen for process capability.

A proposed test, limit, method, unit, precision, sampling, applicability, or reporting change identifies affected products, markets, sites, materials, methods, protocols, batches, open samples, labels, CoAs, reports, quality agreements, and filings.

Impact tasks are concrete: validate or transfer a method, update a dossier, revise stability protocols, retest retained material, notify a customer, retrain a laboratory, or set an effective inventory boundary.

Approval, effective date, first eligible batch, manufacturing date, receipt date, test assignment date, sample pull date, and market release date can each matter. Seal applies a governed transition rule rather than assuming one timestamp fits every process.

Open work is explicitly migrated, grandfathered, canceled, or assessed. The historical specification evaluated at disposition remains frozen with the decision.

When a lot, batch, sample, or stability pull is created, the effective specification resolves required and conditional tests, methods, criteria, sample quantities, laboratories, and completion gates.

The LIMS executes the assigned plan and returns results to the same definition. Manual additions, omissions, substitutions, and cancellations require reason and approval.

Raw observation, calculated result, unit, rounding, significant figures, method, specification, criterion, pass or fail, review, and later re-evaluation remain connected. Changing a current limit does not silently relabel a historical result.

OOS, OOT, atypical, invalid, and pending results open the correct workflow while retaining the original criterion and effective context.

Customer name, market, product description, tests displayed, method references, result formatting, units, statements, signatures, and specifications resolve from approved data. A report can omit an internal test from presentation without omitting it from release.

Generated outputs retain the source version and values used. Regeneration after a correction creates a traceable revision.

The review considers method performance, OOS and OOT, process capability, stability trends, complaints, deviations, pharmacopoeial updates, supplier changes, regulatory commitments, new toxicological knowledge, and product experience.

The outcome can retain, tighten, widen with justification, add or remove tests, change sampling, launch method work, or create a regulatory action. No-change decisions retain the evidence considered.

LIMS should execute tests and calculations; RIMS should retain submission and authority correspondence; document systems should retain approved narrative documents. Seal does not reduce those functions to one generic screen.

It maintains the governed specification objects and relationships that all of those systems consume, including effective-state resolution and cross-system change impact.

Seal is strongest when one specification must remain consistent across CMC, LIMS, stability, raw materials, manufacturing, CoAs, contract laboratories, quality agreements, and batch release. The same object drives work and explains the decision.

If a laboratory only needs static limits for one product, a basic LIMS table may suffice. Seal matters when versions, sites, markets, stages, methods, and commitments make “which specification applies?” a regulated question.

The first implementation should follow one impurity limit from development rationale and registered commitment through approved specification, analytical method, test assignment, results, CoA presentation, stability evaluation, batch disposition, and a later controlled change.

Include a market-specific limit, method version transition, open sample, batch already manufactured, contract laboratory, compendial update, OOS under the old criterion, unit conversion, rounding edge case, and regenerated CoA. The model is ready when every decision resolves the correct effective state without manual interpretation.